QQ客服 官方微博 反馈留言

浏览/检索结果: 共14条，第1-10条 帮助 限定条件 发表日期：2015    专题：西安交通大学    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Effects of RNA-binding protein La on migration and invasion of cervical cancer cells 期刊论文 Journal of Xi'an Jiaotong University (Medical Sciences), 2015, 卷号: 36, 期号: [db:dc_citation_issue], 页码: 345-348 作者:  Chen, Qian;  Chen, Kun-Lun;  Liu, Wei;  Li, Mu;  Gao, Qing 收藏  |  浏览/下载：1/0  |  提交时间：2019/12/02 Cervical cancer  Invasion  RNA interference  RNA-binding protein   Inhibitory effect of EZH2 inhibitor on cervical cancer HeLa cells 期刊论文 Journal of Xi'an Jiaotong University (Medical Sciences), 2015, 卷号: 36, 期号: [db:dc_citation_issue] 作者:  Ding, Mu-Yang;  Jiang, Wen-Jun;  Zhang, Li;  Cui, Yu-Meng;  Zhang, Hang 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/02 Cell proliferation and migration  Cervical cancer cell  Enhancer of zeste homolog 2 (EZH2) inhibitor  Epithelial-mesenchymal transition   Patient age, tumor appearance and tumor size are risk factors for early recurrence of cervical cancer. 期刊论文 Molecular and clinical oncology, 2015, 卷号: 3, 期号: [db:dc_citation_issue], 页码: 363-366 作者:  Wang Juan;  Wang Tao;  Yang Yun-Yi;  Chai Yan-Lan;  Shi Fan 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/02 recurrence  concurrent chemoradiotherapy  radical surgery  cervical cancer   Calcitriol Inhibits Cervical Cancer Cell Proliferation Through Downregulation of HCCR1 Expression 期刊论文 ONCOLOGY RESEARCH, 2015, 卷号: 22, 期号: [db:dc_citation_issue], 页码: 301-309 作者:  Wang, Guoqing;  Lei, Lei;  Zhao, Xixia;  Zhang, Jun;  Zhou, Min 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/02 Calcitriol  Human cervical cancer oncogene (HCCR-1)  HeLa S3 cells   The polycomb group protein enhancer of zeste 2 is a novel therapeutic target for cervical cancer 期刊论文 CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2015, 卷号: 42, 期号: [db:dc_citation_issue], 页码: 458-464 作者:  Ding, Muyang;  Zhang, Hang;  Li, Zhen;  Wang, Cuili;  Chen, Jasmine 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/02 enhancer of zeste 2 inhibitor  xenografts  epithelial-mesenchymal transition  cervical cancer   Knowledge of human papillomavirus vaccination and related factors among parents of young adolescents: a nationwide survey in China 期刊论文 ANNALS OF EPIDEMIOLOGY, 2015, 卷号: 25, 期号: [db:dc_citation_issue], 页码: 231-235 作者:  Zhang, Shao-Kai;  Pan, Xiong-Fei;  Wang, Shao-Ming;  Yang, Chun-Xia;  Gao, Xiao-Hong 收藏  |  浏览/下载：1/0  |  提交时间：2019/12/02 Vaccination  Parents  HPV  Cervical cancer  Knowledge   MicroRNA-494 promotes cervical cancer proliferation through the regulation of PTEN 期刊论文 ONCOLOGY REPORTS, 2015, 卷号: 33, 期号: [db:dc_citation_issue], 页码: 2393-2401 作者:  Yang, Yong-Kang;  Xi, Wen-Yan;  Xi, Ru-Xing;  Li, Jing-Yuan;  Li, Qin 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/02 PTEN  PI3K/Akt  miR-494  proliferation  cervical cancer   Randomized phase III trial of radiotherapy or chemoradiotherapy with topotecan and cisplatin in intermediate-risk cervical cancer patients after radical hysterectomy 期刊论文 BMC CANCER, 2015, 卷号: 15, 期号: [db:dc_citation_issue] 作者:  Sun, Wenze;  Wang, Tao;  Shi, Fan;  Wang, Jiquan;  Wang, Juan 收藏  |  浏览/下载：14/0  |  提交时间：2019/12/02 Topotecan  Intermediate-risk  Chemoradiotherapy  Cisplatin  Cervical cancer   CIP2A cooperates with H-Ras to promote epithelial-mesenchymal transition in cervical-cancer progression 期刊论文 CANCER LETTERS, 2015, 卷号: 356, 期号: [db:dc_citation_issue], 页码: 646-655 作者:  Wu, Yi;  Gu, Ting-Ting;  Zheng, Peng-Sheng 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/02 EMT  CIP2A  MEK/ERK  H-Ras  Cervical-cancer progression   A randomized controlled trial comparing clinical outcomes and toxicity of lobaplatin-versus cisplatin-based concurrent chemotherapy plus radiotherapy and high-dose-rate brachytherapy for FIGO stage II and III cervical cancer 期刊论文 Asian Pacific Journal of Cancer Prevention, 2015, 卷号: 16, 期号: [db:dc_citation_issue], 页码: 5957-5961 作者:  Wang, Ji-Quan;  Wang, Tao;  Shi, Fan;  Yang, Yun-Yi;  Su, Jin 收藏  |  浏览/下载：6/0  |  提交时间：2019/12/02 Chemoradiotherapy  Cisplatin  FIGO stage II and III cervical cancer  Lobaplatin  RCT